Back to Companies
Rein Therapeutics, Inc.
RNTXNasdaqCIK: 0001420565
Over the 10 most recent insider filings, Rein Therapeutics, Inc. (RNTX) has seen activity from 7 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $625.6K bought versus $0 sold, a net purchase of $625.6K. Voss Capital, LP (10% Owner) is the most active by dollar volume, and the single largest transaction was $423.5K by Voss Capital, LP. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$936.7K
Purchases
$625.6K
Sales
$0
Unique Insiders
7
Recent Insider Trades
10 loaded
| May 28 | RNTX Rein Therapeutics, Inc. | VON RICKENBACH JOSEF H | Insider | Buy | $49.6K |
| May 13 | RNTX Rein Therapeutics, Inc. | WINDSOR JAMES BRIAN | Insider | Buy | $25.0K |
| Nov 18 | RNTX Rein Therapeutics, Inc. | Voss Capital, LP | 10% Owner | Buy | $127.6K |
| Oct 28 | RNTX Rein Therapeutics, Inc. | Voss Capital, LP | 10% Owner | Buy | $423.5K |
| Oct 3 | RNTX Rein Therapeutics, Inc. | Voss Capital, LP | 10% Owner | Other | $0 |
| Jul 23 | RNTX Rein Therapeutics, Inc. | Musso Alan A | Insider | Award | $27.1K |
| Jul 23 | RNTX Rein Therapeutics, Inc. | Aivado Manuel | Insider | Award | $27.1K |
| Jul 23 | RNTX Rein Therapeutics, Inc. | Fairey William | Insider | Award | $27.1K |
| Jul 23 | RNTX Rein Therapeutics, Inc. | Ambros Reinhard J. | Insider | Award | $27.1K |
| Jul 23 | RNTX Rein Therapeutics, Inc. | VON RICKENBACH JOSEF H | Insider | Award | $27.1K |
10 filings